2027 ICD-10-CM Diagnosis Code T42.0X6AUnderdosing of hydantoin derivatives, initial encounter
T42.0X6A is a billable ICD-10-CM diagnosis code for underdosing of hydantoin derivatives, initial encounter. The 7th character A marks it as an initial encounter code, used while the patient is receiving active treatment. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 951. The code is not accepted as a principal diagnosis by the Medicare Code Editor. Coders also document this condition as phenytoin taken at lower dose than instructed. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Underdosing of drugs and medicaments, initial encounter.
Code Identity
Code Classification
Code EditsBilling
Medicare Code Editor checks that affect claim validity for T42.0X6A.
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Phenytoin taken at lower dose than instructed
Coding GuidelinesGuidance
Underdosing refers to taking less of a medication than is prescribed by a provider or a manufacturer's instruction. Codes for underdosing should never be assigned as principal or first-listed codes. If a patient has a relapse or exacerbation of the medical condition for which the drug is prescribed because of the reduction in dose, then the medical condition itself should be coded.
The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42). Use the following options for the applicable episode of care:
- A - initial encounter
- D - subsequent encounter
- S - sequela
Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2027, published by CMS and the National Center for Health Statistics.
Instructional NotesGuidance
Instructions from the official ICD-10-CM Tabular List that apply to T42.0X6A: its own notes plus those printed at T42, block T36-T50, and Chapter 19. A note printed at a category, block or chapter applies to every code under it.
Includes
Further defines, or gives examples of, the content of the category.
- adverse effect of correct substance properly administered
- poisoning by overdose of substance
- poisoning by wrong substance given or taken in error
- underdosing by (inadvertently) (deliberately) taking less substance than prescribed or instructed
Excludes1
Not coded here: the excluded code is never reported together with this one, unless the two conditions are unrelated.
- toxic reaction to local anesthesia in pregnancy (O29.3-)
Excludes2
Not included here: the excluded condition is not part of this code, but a patient may have both, so both codes may be reported.
Code First
The underlying condition named in the note is sequenced before this code.
Use Additional Code
Add a second code, after this one, to fully describe the condition.
- code to identify any retained foreign body, if applicable (Z18.-)
Notes
General instructions on how these codes are used.
- Use secondary code(s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code
- The chapter uses the S-section for coding different types of injuries related to single body regions and the T-section to cover injuries to unspecified body regions as well as poisoning and certain other consequences of external causes.
7th Character
Every code in the category takes a 7th character from the listed values, with the placeholder X filling any empty positions before it.
- The appropriate 7th character is to be added to each code from category T42
- Ainitial encounter this code
- Dsubsequent encounter
- Ssequela
Source: CMS ICD-10-CM Tabular List. How to read instructional notes.
Referenced in Other NotesGuidance
Instructional notes printed at other codes that name T42.0X6A, its category, or a range that includes it.
Excludes2 1
These codes carry an Excludes2 note naming T42.0X6A: its condition is not part of those codes, and both may be reported when the patient has both.
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Mephenytoin
an anticonvulsant effective in tonic-clonic epilepsy (epilepsy, tonic-clonic). it may cause blood dyscrasias.Phenytoin
an anticonvulsant that is used to treat a wide variety of seizures. it is also an anti-arrhythmic and a muscle relaxant. the mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. the mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs.
Table of Drugs and ChemicalsClinical
Substances in the Table of Drugs and Chemicals that reference this code family. Always confirm in the Tabular List before coding.
| Substance | Accidental | Self-harm | Assault | Undetermined | Adverse Effect | Underdosing |
|---|---|---|---|---|---|---|
| Albutoin | T42.0X1 | T42.0X2 | T42.0X3 | T42.0X4 | T42.0X5 | T42.0X6 |
| Anticonvulsant::hydantoin | T42.0X1 | T42.0X2 | T42.0X3 | T42.0X4 | T42.0X5 | T42.0X6 |
| Dilantin | T42.0X1 | T42.0X2 | T42.0X3 | T42.0X4 | T42.0X5 | T42.0X6 |
| Diphenylhydantoin | T42.0X1 | T42.0X2 | T42.0X3 | T42.0X4 | T42.0X5 | T42.0X6 |
| Epanutin | T42.0X1 | T42.0X2 | T42.0X3 | T42.0X4 | T42.0X5 | T42.0X6 |
| Ethotoin | T42.0X1 | T42.0X2 | T42.0X3 | T42.0X4 | T42.0X5 | T42.0X6 |
| Hydantoin derivative NEC | T42.0X1 | T42.0X2 | T42.0X3 | T42.0X4 | T42.0X5 | T42.0X6 |
| Mephenytoin | T42.0X1 | T42.0X2 | T42.0X3 | T42.0X4 | T42.0X5 | T42.0X6 |
| Metetoin | T42.0X1 | T42.0X2 | T42.0X3 | T42.0X4 | T42.0X5 | T42.0X6 |
| Methetoin | T42.0X1 | T42.0X2 | T42.0X3 | T42.0X4 | T42.0X5 | T42.0X6 |
| Methoin | T42.0X1 | T42.0X2 | T42.0X3 | T42.0X4 | T42.0X5 | T42.0X6 |
| Phenantoin | T42.0X1 | T42.0X2 | T42.0X3 | T42.0X4 | T42.0X5 | T42.0X6 |
| Phenytoin | T42.0X1 | T42.0X2 | T42.0X3 | T42.0X4 | T42.0X5 | T42.0X6 |
Patient EducationClinical
Medication Errors
Medicines treat infectious diseases, prevent problems from chronic diseases, and ease pain. But medicines can also cause harmful reactions if not used correctly. Errors can happen in the hospital, at the health care provider's office, at the pharmacy, or at home. You can help prevent errors by:
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert T42.0X6A to ICD-9-CMHistory
Code HistoryHistory
Questions About T42.0X6AOverview
What is the ICD-10 code for underdosing of hydantoin derivatives, initial encounter?
The ICD-10-CM code for underdosing of hydantoin derivatives, initial encounter is T42.0X6A (sometimes written as T420X6A). It is billable on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
Is T42.0X6A (Underdosing of hydantoin derivatives) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report underdosing of hydantoin derivatives, initial encounter on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
What does the 7th character A in T42.0X6A mean?
The final character A marks the initial encounter: use it while the patient is receiving active treatment for underdosing of hydantoin derivatives, such as an emergency visit or first evaluation.
What MS-DRG does T42.0X6A group to?
On inpatient claims, underdosing of hydantoin derivatives, initial encounter maps to MS-DRG 951 (other Factors Influencing Health Status), which carries a relative weight of 0.5574. Higher weights mean higher Medicare reimbursement.
Can T42.0X6A be a principal diagnosis?
No. The Medicare Code Editor rejects this code as a principal diagnosis because underdosing of hydantoin derivatives, initial encounter describes a circumstance that influences health status rather than a current illness. Report it as a secondary diagnosis.